About TFSCRO
TFSCRO is a company based in Lund (Sweden) founded in 1996 was acquired by Ratos in September 2015. TFSCRO has completed 2 acquisitions, including Appletree CI Group and SCIderm. TFSCRO offers products and services including Clinical Development, Resourcing Solutions, and Functional Services (FSP). TFSCRO operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Lund, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tfs Trial Form Support Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Appletree CI Group
& 1 more
-
Acquired by
Ratos
(Sep 07, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TFSCRO
TFSCRO offers a comprehensive portfolio of products and services, including Clinical Development, Resourcing Solutions, and Functional Services (FSP).
Services for clinical trial phases I-III and real-world evidence.
Flexible staffing for clinical projects and expertise support.
End-to-end clinical workforce management solutions.
People of TFSCRO
Unlock access to complete
Unlock access to complete
Funding Insights of TFSCRO
Detailed funding history for TFSCRO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in TFSCRO
TFSCRO has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ratos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on consumer, industry, construction, and services sectors
|
Locked | Locked | Locked |
Investor details for TFSCRO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TFSCRO
TFSCRO has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Appletree CI Group and SCIderm.
Investment portfolio details for TFSCRO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A contract research organization with experience in development of ophthalmology drugs and medical devices
|
Locked | Locked | 2013 | Locked | |
|
CRO focussed exclusively in dermatology, allergology, aesthetic drug development and device certification services
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for TFSCRO
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TFSCRO
Detailed financials for TFSCRO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tfscro Comparisons
Peer comparison for TFSCRO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TFSCRO
TFSCRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
Detailed competitors of TFSCRO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tfscro
Complete news archive for TFSCRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TFSCRO
TFSCRO was founded in 1996.
TFSCRO is headquartered in Lund, Sweden.
Markus Granlund is the current CEO of TFSCRO.
TFS was founded in 1996 in Lund, Sweden, and operates as a mid-sized contract research organization in the pharmaceutical, biotech, and medical device sectors. Clinical research services are delivered to clients worldwide, including scientific advice, product development consulting, protocol design, regulatory affairs strategy, and interactions with global agencies. Assistance with submissions such as CTAIND and orphan drug designations is also offered, supporting operations across healthcare and life sciences.
TFSCRO's top competitors include Emmes, Syneos Health and ClinChoice.
TFSCRO offers Clinical Development, Resourcing Solutions, and Functional Services (FSP).
TFSCRO has made 2 acquisitions, including Appletree CI Group, and SCIderm.
TFSCRO has 1 investor. Key investors include Ratos.